Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricONCBeOne Medicines AGBIIBBiogenMRNAModerna
Snapshot
Price$316.66$202.70$59.47
Market cap$33.43B$31.91B$31.65B
Valuation
P/E71.9x21.8x—
Forward P/E—23.7x—
Growth
Revenue growth36.2%1.2%-30.0%
EPS growth—-8.1%—
Profitability
Net margin7.8%13.8%-143.6%
ROE5.2%7.5%-36.7%
Balance sheet & cash
Debt / equity0.25x0.34x0.07x
Free cash flow yield—6.8%-13.6%
Dividend yield———
Verdict
Investment ratingNeutral· 48Neutral· 49Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearONCtoday $317BIIBtoday $203MRNAtoday $59
2027$323.42 – $474.35+50% CAGR$155.07 – $227.43+12% CAGR$45.49 – $66.73+12% CAGR
2028$440.43 – $645.97+43% CAGR$158.17 – $231.98+7% CAGR$46.40 – $68.06+7% CAGR
2029$599.78 – $879.68+41% CAGR$161.33 – $236.62+5% CAGR$47.33 – $69.42+5% CAGR
2030$816.79 – $1,197.95+39% CAGR$164.56 – $241.35+4% CAGR$48.28 – $70.81+4% CAGR
2031$1,112.30 – $1,631.37+39% CAGR$167.85 – $246.18+4% CAGR$49.24 – $72.23+4% CAGR
5-yr CAGR28.6% – 38.8%-3.7% – 4.0%-3.7% – 4.0%